Sarcopenic Obesity: Prevalence and Association With Metabolic Syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA)
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: We investigated the prevalence of sarcopenic obesity (SO) and its relationship with metabolic syndrome in a community-based elderly cohort in Korea. RESEARCH DESIGN AND METHODS: In this study, 287 men and 278 women aged 65 or older were recruited. Sarcopenia was defined as the appendicular skeletal muscle mass (ASM) divided by height squared (Ht2) (kg/m2) or by weight (Wt) (%) of <1 SD below the sex-specific mean for young adults. Obesity was defined as a visceral fat area ≥100 cm2. RESULTS: The prevalence of SO was 16.7% in men and 5.7% in women with sarcopenia defined by ASM/Ht2; however, it was 35.1% in men and 48.1% in women by ASM/Wt. Using ASM/Wt, the homeostasis model assessment of insulin resistance of subjects with SO was higher and they were at higher risk for metabolic syndrome (odds ratio [OR] 8.28 [95% CI 4.45–15.40]) than the obese (5.51 [2.81–10.80]) or sarcopenic group (2.64 [1.08–6.44]). CONCLUSIONS: SO defined by ASM/Wt was more closely associated with metabolic syndrome than either sarcopenia or obesity alone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Most clinical studies have reported that sarcopenic obesity is associated with metabolic syndrome [136,137,138].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [137]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Lim et al. observed a higher risk of metabolic syndrome among adults with sarcopenic obesity [defined using DXA-measured ALM/weight (%) and visceral fat area] [odds ratio (OR): 8.28, 95% CI: 4.45–15.40] than among those with obesity (OR: 5.51, 95% CI: 2.81–10.80) or sarcopenia (OR: 2.64, 95% CI: 1.08–6.44) in a cross-sectional study of 565 participants aged ≥65 years from the Korean Longitudinal”
From Health Consequences of Sarcopenic Obesity: A Narrative Review (2020) · cites this paper as [89]
In the citing paper
“In contrast, using the definition ALM/ht2, the ORs of metabolic syndrome were lower in the obesity group than in the sarcopenic obesity group (2.90 [95% CI: 1.28–6.57] vs. 4.80 [95% CI: 2.63–8.75]) (89).”
From Health Consequences of Sarcopenic Obesity: A Narrative Review (2020) · cites this paper as [89]
In the citing paper
“Regarding body FM, the upper sex-specific cut-offs of 40% for females and 30% for males have been proposed as best predictors of mortality in the NHANES sample (American population) using DXA [59].”
From Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement (2022) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Epidemiology of Sarcopenia among the Elderly in New Mexico
Baumgartner, R. N., Koehler, K. M., Gallagher, D., Romero, L., Heymsfield, S. B., Ross, R. R., Garry, P. J., & Lindeman, R. D. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009520 · Cited by 4,004 · cited 1×
“(4) and 2) ASM as a percentage of body weight (ASM/Wt), which was modified from the study of Janssen et al.”
MethodJanssen, I., Heymsfield, S. B., & Ross, R. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50216.x · Cited by 3,139
Newman, A. B., Kupelian, V., Visser, M., Simonsick, E. M., Goodpaster, B. H., Kritchevsky, S. B., Tylavsky, F. A., Rubin, S. M., Harris, T. B., & on Behalf of the Health, A. A. B. C. S. I. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.1.72 · Cited by 1,692
Body Composition in Healthy Aging
BAUMGARTNER, R. N. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06498.x · Cited by 1,078
Sarcopenic obesity: A new category of obesity in the elderly
Zamboni, M., Mazzali, G., Fantin, F., Rossi, A., & Di Francesco, V. (2008) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.10.002 · Cited by 953 · cited 1×
“Second, previous studies used BMI or the percentage of fat mass for the definition of obesity to obtain a sufficient number of subjects within the group for statistical analysis (14).”
MethodSarcopenic Obesity Predicts Instrumental Activities of Daily Living Disability in the Elderly
Baumgartner, R. N., Wayne, S. J., Waters, D. L., Janssen, I., Gallagher, D., & Morley, J. E. (2004) · Obesity Research · doi:10.1038/oby.2004.250 · Cited by 937 · cited 1×
“(1) showed that the prevalence of metabolic syndrome was highest in the group of nonsarcopenic obese subjects.”
BackgroundNew Criteria for `Obesity Disease' in Japan
Oda, E. (2006) · Circulation Journal · doi:10.1253/circj.70.150 · Cited by 783
Sarcopenic obesity and inflammation in the InCHIANTI study
Schrager, M. A., Metter, E. J., Simonsick, E., Ble, A., Bandinelli, S., Lauretani, F., & Ferrucci, L. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00627.2006 · Cited by 594 · cited 1×
“These factors activate a vicious cycle leading to accelerated sarcopenia, additional weight gain largely in the form of fat, and ultimately to physical disability (1, 9-12).”
Background
Research works printed but not linked: 1
- World Health Organization Western Pacific Region, 2000, The Asia-Pacific perspective: redefining obesity and its treatment
Cited by
Items 101–200 of 593
Najm, A., Niculescu, A.-G., Grumezescu, A. M., & Beuran, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084300 · Cited by 96
IL-15 Promotes Human Myogenesis and Mitigates the Detrimental Effects of TNFα on Myotube Development
O’Leary, M. F., Wallace, G. R., Bennett, A. J., Tsintzas, K., & Jones, S. W. (2017) · Scientific Reports · doi:10.1038/s41598-017-13479-w · Cited by 85
Association between sarcopenia level and metabolic syndrome
Kim, S. H., Jeong, J. B., Kang, J., Ahn, D., Kim, J. W., Kim, B. G., Lee, K. L., Oh, S., Yoon, S. H., Park, S. J., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0248856 · Cited by 97
Self-citationPeng, T.-C., Wu, L.-W., Chen, W.-L., Liaw, F.-Y., Chang, Y.-W., & Kao, T.-W. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2017.11.021 · Cited by 84
Oh, C., Jho, S., No, J.-K., & Kim, H. (2014) · Nutrition Research · doi:10.1016/j.nutres.2014.07.018 · Cited by 82
Moreira, M. A., Zunzunegui, M. V., Vafaei, A., da Câmara, S. M. A., Oliveira, T. S., & Maciel, Á. C. C. (2015) · BMC Public Health · doi:10.1186/s12889-015-2667-4 · Cited by 88
“Sarcopenia and obesity may act synergistically, leading to functional and metabolic changes [62], and our results provide evidence for this synergism by showing the decline in the chair standing performance in SO participants.”
ResultAn, K. O., & Kim, J. (2016) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2016.07.005 · Cited by 81
Self-citationSeo, M. H., Kim, M. K., Park, S. E., Rhee, E. J., Park, C. Y., Lee, W.-Y., Baek, K. H., Song, K.-H., Kang, M. I., & Oh, K. W. (2013) · Endocrine Journal · doi:10.1507/endocrj.ej12-0395 · Cited by 81
Saito, H., Matsue, Y., Kamiya, K., Kagiyama, N., Maeda, D., Endo, Y., Ueno, H., Yoshioka, K., Mizukami, A., Saito, K., et al. (2022) · BMC Geriatrics · doi:10.1186/s12877-022-03168-3 · Cited by 78
“adjusted by body weight than by height squared [28].”
MethodSeo, J. A., Cho, H., Eun, C. R., Yoo, H. J., Kim, S. G., Choi, K. M., Baik, S. H., Choi, D. S., Park, M. H., Han, C., et al. (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.03887.x · Cited by 73
Lee, M. J., Kim, E., Bae, S.-J., Kim, G., Park, S. W., Choe, J., Jung, C. H., Lee, W. J., & Kim, H. (2018) · Gut and Liver · doi:10.5009/gnl18070 · Cited by 84
“Because skeletal muscle is the primary tissue responsible for insulin-mediated glucose disposal, loss of muscle mass causes glucose intolerance and increases insulin resistance.(5) Increased insulin resistance results in lipolysis, and increased delivery of free fatty acids to the liver may enhance hepatic fat accumul…”
BackgroundPrevalence of sarcopenia in Mexico City
Arango-Lopera, V. E., Arroyo, P., Gutiérrez‐Robledo, L. M., & Pérez‐Zepeda, M. U. (2012) · European Geriatric Medicine · doi:10.1016/j.eurger.2011.12.001 · Cited by 93
“Also regarding to BMI, sarcopenic obesity was found in a very low proportion in comparison to other reports, this might be due to the sample and the greater mean age of our study [27].”
ResultAuyeung, T. W., Lee, J. S. W., Leung, J. C. S., Kwok, T. C. Y., & Woo, J. (2012) · AGE · doi:10.1007/s11357-012-9423-9 · Cited by 83
“…Kong e-mail: auyeungtw@cuhk.edu.hk J. S. W. Lee : T. Kwok : J. Woo Division of Geriatrics, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong J. Leung The Jockey Club Centre for Osteoporosis Care, The Chinese University of Hong Kong, Shatin, Hong Kong”
InfluentialLong noncoding RNAs in diseases of aging
Kim, J., Kim, K. M., Noh, J. H., Yoon, J., Abdelmohsen, K., & Gorospe, M. (2015) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2015.06.013 · Cited by 82
Self-citationCambios fisiológicos asociados al envejecimiento
Salech, M. F., Jara, L. R., & Michea, A. (2012) · Revista Médica Clínica Las Condes · doi:10.1016/s0716-8640(12)70269-9 · Cited by 241
Perna, S., Peroni, G., Faliva, M. A., Bartolo, A., Naso, M., Miccono, A., & Rondanelli, M. (2017) · Aging Clinical and Experimental Research · doi:10.1007/s40520-016-0701-8 · Cited by 77
Cho, Y., Shin, S.-Y., & Shin, M.-J. (2015) · Nutrition Research · doi:10.1016/j.nutres.2015.04.002 · Cited by 75
Domiciano, D. S., Figueiredo, C. P., Lopes, J., Caparbo, V. F., Takayama, L., Menezes, P. R., Bonfá, E., & Pereira, R. M. R. (2012) · Osteoporosis International · doi:10.1007/s00198-012-2002-1 · Cited by 95
Batsis, J. A., Zbehlik, A. J., Pidgeon, D., & Bartels, S. J. (2015) · BMC Geriatrics · doi:10.1186/s12877-015-0118-9 · Cited by 74
“mass, obesity and their long-term outcomes [2, 8, 9].”
Kim, K.-E., Jang, S., Lim, S. K., Park, Y. J., Paik, N., Kim, K. W., Jang, H. C., & Lim, J. (2012) · Age and Ageing · doi:10.1093/ageing/afs115 · Cited by 87
“0.86* (0.78–0.95) 0.89 (0.77–1.03) 0.84* (0.73–0.97) 0.86* (0.77–0.96) 0.89 (0.71–1.11) 0.87* (0.69–0.94) ASM/Ht2 (kg/m2) 0.48* (0.32–0.71) 0.78 (0.42–1.46) 0.41* (0.23–0.73) 0.90 (0.57–1.41) 1.11 (0.44–2.76) 0.97 (0.56–1.70) Peak torque 0.97* (0.95–0.98) 0.91* (0.86–0.97) 0.98 (0.96–1.00) 0.94* (0.92–0.96) 0.83 (0.73…”
BackgroundMethodInfluentialSelf-citationWijarnpreecha, K., Kim, D., Raymond, P., Scribani, M., & Ahmed, A. (2019) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001397 · Cited by 77
Sarcopenia and risk of nonalcoholic fatty liver disease: A meta-analysis
Wijarnpreecha, K., Panjawatanan, P., Thongprayoon, C., Jaruvongvanich, V., & Ungprasert, P. (2018) · Saudi Journal of Gastroenterology · doi:10.4103/sjg.sjg_237_17 · Cited by 72
Scott, D., Park, M. S., Kim, T. N., Ryu, J. Y., Hong, H. C., Yoo, H. J., Baik, S. H., Jones, G., & Choi, K. M. (2016) · The Journal of nutrition, health and aging · doi:10.1007/s12603-015-0559-z · Cited by 70
“In an analysis of over 500 adults aged 65 years and over in the Korean Longitudinal Study on Health and Aging (KLoSHA), participants with sarcopenia defined by aLM/Wt had approximately two and a half times increased likelihood of MetS (9).”
Brazilian green propolis improves gut microbiota dysbiosis and protects against sarcopenic obesity
Okamura, T., Hamaguchi, M., Bamba, R., Nakajima, H., Yoshimura, Y., Kimura, T., Hashimoto, Y., Majima, S., Senmaru, T., Ushigome, E., et al. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13076 · Cited by 76
Kang, S.-Y., Lim, G. E., Kim, Y. K., Kim, H. W., Lee, K., Park, T.-J., & Kim, J. (2017) · Journal of Bone Metabolism · doi:10.11005/jbm.2017.24.1.9 · Cited by 69
Self-citationSarcopenia and sarcopenic obesity classifications and cardiometabolic risks in older women
dos Santos, E. P., Gadelha, A. B., Safons, M. P., Nóbrega, O. T., Oliveira, R. J., & Lima, R. M. (2014) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2014.03.012 · Cited by 69
“Please cite this article in press as: dos Santos, E.P., et al., Sarcopenia a older women. Arch. Gerontol. Geriatr. (2014), http://dx.”
Mid-adulthood cardiometabolic risk factor profiles of sarcopenic obesity
Ma, J., Hwang, S., McMahon, G. M., Curhan, G. C., Mclean, R. R., Murabito, J. M., & Fox, C. S. (2016) · Obesity · doi:10.1002/oby.21356 · Cited by 68
Kim, T. N., Park, M. S., Kim, Y. J., Lee, E. J., Kim, M.-K., Kim, J. M., Ko, K. S., Rhee, B. D., & Won, J. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100118 · Cited by 78
“Low muscle mass was defined as a SMI of 1 standard deviation (SD) below the sex-specific mean value for the young reference group [17,18].”
BackgroundSelf-citationSong, W., Kim, S., Lim, S. K., Park, Y. J., Kim, M., Lee, S. M., Lee, S.-B., Kim, K.-W., Jang, H. C., Cho, S., et al. (2012) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2012.07.017 · Cited by 72
Self-citationAdverse effects of coexistence of sarcopenia and metabolic syndrome in Japanese women
Sanada, K., Iemitsu, M., Murakami, H., Gando, Y., Kawano, H., Kawakami, R., Tabata, I., & Miyachi, M. (2012) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2012.43 · Cited by 72
Geriatrics Fact Sheet in Korea 2018 From National Statistics
Jang, I., Lee, H., & Lee, E. (2019) · Annals of Geriatric Medicine and Research · doi:10.4235/agmr.19.0013 · Cited by 67
Scott, D., Cumming, R., Naganathan, V., Blyth, F., Le Couteur, D. G., Handelsman, D. J., Seibel, M., Waite, L. M., & Hirani, V. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2018.04.006 · Cited by 65
“In cross-sectional studies, Korean older adults with sarcopenic obesity (defined as low appendicular lean mass [ALM] and high visceral fat area) are eight times as likely to develop MetS compared with obese or sarcopenic alone (Lim et al., 2010), and have increased risk of insulin resistance, MetS, and cardiovascular…”
Yang, E. J., Lim, S. K., Lim, J., Kim, K. W., Jang, H. C., & Paik, N. (2011) · Metabolism · doi:10.1016/j.metabol.2011.07.005 · Cited by 72
Self-citationMoon, J. H., Kong, M. H., & Kim, H. J. (2015) · Journal of Korean Medical Science · doi:10.3346/jkms.2015.30.11.1682 · Cited by 72
“Low muscle mass (LMM) was defined as a value of ASM divided by weight (ASM/Wt, %) that was two standard deviations below the sex-specific mean of the young reference group (12,13).”
BackgroundPark, M., Hwang, S. Y., Kim, N. H., Kim, S. G., Choi, K. M., Baik, S. H., & Yoo, H. J. (2023) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes23005 · Cited by 68
Kim, J., & Park, Y. S. (2016) · Nutrition Research · doi:10.1016/j.nutres.2016.09.013 · Cited by 63
“12 and most studies investigating MetS or the associated CVD risk have adopted the weightadjusted method [12, 14, 22, 24, 25].”
MethodSelf-citationAdditional role of sarcopenia to waist circumference in predicting the odds of metabolic syndrome
Park, S. H., Park, J. H., Park, H. Y., Jang, H. J., Kim, H. K., Park, J., Shin, K. J., Lee, J. G., & Moon, Y. S. (2013) · Clinical Nutrition · doi:10.1016/j.clnu.2013.08.008 · Cited by 61
Self-citationOh, C., Jeon, B. H., Reid Storm, S. N., Jho, S., & No, J.-K. (2017) · Nutrition · doi:10.1016/j.nut.2016.06.004 · Cited by 60
Sarcopenia and liver transplant: The relevance of too little muscle mass
Kallwitz, E. R. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i39.10982 · Cited by 63
Sarcopenia in aging, obesity, and cancer
Ligibel, J. A., Schmitz, K. H., & Berger, N. A. (2020) · Translational Cancer Research · doi:10.21037/tcr-2019-eaoc-05 · Cited by 65
Azevedo, V. Z., Silaghi, C. A., Maurel, T., Silaghi, H., Ratziu, V., & Pais, R. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2021.774030 · Cited by 67
Association of the triglyceride and glucose index with low muscle mass: KNHANES 2008–2011
Kim, J. A., Hwang, S. Y., Yu, J. H., Roh, E., Hong, S., Lee, Y., Kim, N. H., Yoo, H. J., Seo, J. A., Kim, N. H., et al. (2021) · Scientific Reports · doi:10.1038/s41598-020-80305-1 · Cited by 59
Self-citationComparison of height‐ and weight‐adjusted sarcopenia in a T aiwanese metropolitan older population
Meng, N., Li, C., Liu, C.-S., Lin, C., Wen‐Yuan, L., Chang, C., Li, T., & Lin, C. (2014) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12227 · Cited by 62
Nishigori, T., Tsunoda, S., Obama, K., Hisamori, S., Hashimoto, K., Itatani, Y., Okada, K., & Sakai, Y. (2018) · Annals of Surgical Oncology · doi:10.1245/s10434-018-6728-7 · Cited by 63
Hsieh, Y., Joo, S. K., Koo, B. K., Lin, H., & Kim, W. K. (2020) · Liver International · doi:10.1111/liv.14719 · Cited by 60
Food and addiction among the ageing population
Murray, S. M., Kroll, C., & Avena, N. M. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.10.002 · Cited by 56
Fatty Liver Index Associates with Relative Sarcopenia and GH/ IGF- 1 Status in Obese Subjects
Poggiogalle, E., Lubrano, C., Gnessi, L., Mariani, S., Lenzi, A., & Donini, L. M. (2016) · PLOS ONE · doi:10.1371/journal.pone.0145811 · Cited by 56
Kim, J., & Park, Y. S. (2017) · Nutrition Research · doi:10.1016/j.nutres.2017.04.004 · Cited by 61
Self-citationChoe, H. J., Cho, B., Park, Y. S., Roh, E., Kim, H. J., Lee, S., Kim, B., Kim, M., Won, C. W., Park, K. S., et al. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12993 · Cited by 59
Self-citationPeterson, M. D., Zhang, P., Haapala, H. J., Wang, S. C., & Hurvitz, E. A. (2015) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2015.06.007 · Cited by 55
Peterson, M. D., Al Snih, S., Stoddard, J., Shekar, A., & Hurvitz, E. A. (2014) · Preventive Medicine · doi:10.1016/j.ypmed.2013.12.014 · Cited by 53
Effect of Sarcopenia and Body Shape on Cardiovascular Disease According to Obesity Phenotypes
Cho, H.-W., Chung, W., Moon, S., Ryu, O., Kim, M. K., & Kang, J. G. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0223 · Cited by 55
“penia and obesity was more likely associated with metabolic disorders and morbidity [24-28].”
BackgroundChoudhary, N. S., Saigal, S., Saraf, N., Mohanka, R., Rastogi, A. N., Goja, S. K., Menon, P. B., Mishra, S. K., Mittal, A., & Soin, A. S. (2014) · Clinical Transplantation · doi:10.1111/ctr.12505 · Cited by 55
“We found sarcopenic obesity in an alarming proportion of our study cohort (88%), which is clearly very high when compared to the available data in literature (27).”
BackgroundResultHwang, J., & Park, S. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20021140 · Cited by 52
“A Korean longitudinal study [40] described that the triglyceride level in male SO (149.”
BackgroundResultLu, Y., Tsai, Y., Chou, R., Kuo, C., Chang, C. C., Huang, P., & Lin, S. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.01.024 · Cited by 53
Sarcopenia in non-alcoholic fatty liver disease: Targeting the real culprit?
Merli, M., & Dasarathy, S. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.05.014 · Cited by 51
“By analyzing the same database, previous studies had shown that, during aging, the increase in fat mass and the decrease in muscle mass resulted in an increase in metabolic disorders [5].”
MethodHwang, Y.-C., Jeon, W. S., Park, C.-Y., & Youn, B.-S. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0319-8 · Cited by 50
Pal, P., Palui, R., & Ray, S. (2021) · World Journal of Hepatology · doi:10.4254/wjh.v13.i11.1584 · Cited by 55
Sarcopenic Obesity and Outcomes for Patients With Cancer
Liu, C., Liu, T., Deng, L., Zhang, Q., Song, M., Shi, J., Liu, C., Xie, H., Chen, Y., Lin, S., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.17115 · Cited by 57
Ikeda, Y., Imao, M., Satoh, A., Watanabe, H., Hamano, H., Horinouchi, Y., Izawa-Ishizawa, Y., Kihira, Y., Miyamoto, L., Ishizawa, K., et al. (2016) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2016.01.011 · Cited by 50
“Loss of skeletal muscle mass, also called muscle atrophy or saropenia, is induced by aging [1] and various chronic diseases such as eart failure [2], chronic kidney disease [3], diabetes [4] and other etabolic syndromes [5].”
BackgroundThe Prevalence of Presarcopenia in Asian Indian Individuals With and Without Type 2 Diabetes
Anbalagan, V. P., Venkataraman, V., Pradeepa, R., Deepa, M., Anjana, R. M., & Mohan, V. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0068 · Cited by 55
Sarcopenia and Obesity: Gender-Different Relationship with Functional Limitation in Older Persons
Kim, J. H., Choi, S. H., Lim, S. K., Yoon, J. W., Kang, S. M., Kim, K. W., Lim, J., Cho, N. H., & Jang, H. C. (2013) · Journal of Korean Medical Science · doi:10.3346/jkms.2013.28.7.1041 · Cited by 57
“Sarcopenia is associated with metabolic syndromes (4, 5) and more importantly, with frailty due to functional limitation (1-3, 6-9).”
Self-citationIkeda, Y., Satoh, A., Horinouchi, Y., Hamano, H., Watanabe, H., Imao, M., Imanishi, M., Zamami, Y., Takechi, K., Izawa‐Ishizawa, Y., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201802724rr · Cited by 50
Koo, H., Joo-Hyun, P., Park, H. K., Jung, H., & Lee, S.-S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110448 · Cited by 50
Koo, B. K., Roh, E., Yang, Y. S., & Moon, M. K. (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12392 · Cited by 48
The Impact of Dysmetabolic Sarcopenia Among Insulin Sensitive Tissues: A Narrative Review
Armandi, A., Rosso, C., Caviglia, G. P., Ribaldone, D. G., & Bugianesi, E. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.716533 · Cited by 48
“Hence, the modified index ASM/weight has been proposed to better quantify sarcopenia across metabolic disturbances (20).”
BackgroundKim, Y., Han, B., Han, K., Shin, K. E., Lee, H., Kim, T. R., Cho, K.-H., Kim, D., Kim, Y., Kim, H., et al. (2015) · Endocrine · doi:10.1007/s12020-015-0577-y · Cited by 49
Diabetes, body fat, skeletal muscle, and hypertension: The ominous chiasmus?
Shu, J., Matarese, A., & Santulli, G. (2018) · Journal of Clinical Hypertension · doi:10.1111/jch.13453 · Cited by 50
Kemmler, W., von Stengel, S., Engelke, K., Sieber, C., & Freiberger, E. (2016) · Osteoporosis International · doi:10.1007/s00198-015-3303-y · Cited by 47
Tallis, J. A., Shelley, S. P., Degens, H., & Hill, C. (2021) · Biomolecules · doi:10.3390/biom11030372 · Cited by 48
Irisin is a predictor of sarcopenic obesity in type 2 diabetes mellitus: A cross-sectional study
Oguz, A., Sahin, M., Tuzun, D., Kurutas, E. B., Ulgen, C., Bozkus, O., & Gul, K. (2021) · Medicine · doi:10.1097/md.0000000000026529 · Cited by 46
“1% in women by ASM (%) defined sarcopenia.([5]) Low et al([37]) reported the prevalence of SO defined by using the FM/FFM ratio as 19.”
BackgroundMethodSex differences of sarcopenia in Asian populations: The implications in diagnosis and management
Wu, Y., Hwang, A., Liu, L.-K., Peng, L., & Chen, L. (2016) · Journal of Clinical Gerontology and Geriatrics · doi:10.1016/j.jcgg.2016.04.001 · Cited by 52
Sarcopenia and non-alcoholic fatty liver disease: Is there a relationship? A systematic review
Tovo, C. V., Fernandes, S. A., Buss, C., & de Mattos, Â. A. (2017) · World Journal of Hepatology · doi:10.4254/wjh.v9.i6.326 · Cited by 45
Roh, E., Hwang, S. Y., Yoo, H. J., Baik, S. H., Lee, J., Son, S. J., Kim, H. J., Park, Y. S., Lee, S., Cho, B., et al. (2021) · Hepatology International · doi:10.1007/s12072-021-10258-8 · Cited by 49
“reported a positive correlation between ASM/height2 and BMI, visceral fat area, and insulin resistance, whereas ASM/weight was negatively correlated with these metabolic risk parameters [24].”
BackgroundSelf-citationSon, J., Yu, Q., & Seo, J.-S. (2019) · Nutrition Research and Practice · doi:10.4162/nrp.2019.13.1.47 · Cited by 44
Jeng, C., Zhao, L., Wu, K., Zhou, Y., Chen, T., & Deng, H. (2018) · JCSM Clinical Reports · doi:10.17987/jcsm-cr.v3i2.27 · Cited by 54
Cho, Y. H., Do, K., Chae, E. J., Choi, S., Jo, K., Lee, S., & Hong, S. (2019) · Korean Journal of Radiology · doi:10.3348/kjr.2018.0241 · Cited by 47
“One study conducted on a large number of Korean patients reported that the weight-adjusted parameter of the muscle mass of a patient was a more powerful risk factor for development of metabolic syndrome than the height-adjusted parameter (39).”
BackgroundSelf-citationLuo, Y., Wang, Y., Tang, S., Xu, L., Zhao, X., Han, M., Liu, Y., Xu, Y. J., & Han, B. (2024) · BMC Geriatrics · doi:10.1186/s12877-024-04952-z · Cited by 45
“Most studies were of fair [6, 8, 10, 2–13, 16, 19, 25–26, 29, 31, 32, 35–37, 42, 48, 51–53] or high [7, 9, 15, 21–25, 28–29, 31, 33, 35, 36, 40–43, 45, 49, 51, 52–56] quality because they scored “yes” for at least five items in the quality assessment checklist.”
BackgroundLimpawattana, P., Kotruchin, P., & Pongchaiyakul, C. (2015) · Osteoporosis and Sarcopenia · doi:10.1016/j.afos.2015.10.001 · Cited by 61
Furushima, T., Miyachi, M., Iemitsu, M., Murakami, H., Kawano, H., Gando, Y., Kawakami, R., & Sanada, K. (2017) · Journal of PHYSIOLOGICAL ANTHROPOLOGY · doi:10.1186/s40101-017-0130-1 · Cited by 42
“previously compared risk factors for metabolic syndrome in Korean individuals with sarcopenia defined by height-adjusted and weight-adjusted ASM [13].”
Kim, S.-W., & Kim, R. (2020) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001509 · Cited by 46
Yoo, J. H., Park, S. W., Jun, J. E., Jin, S., Hur, K. Y., Lee, M., Kang, M., Kim, G., & Kim, J. H. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3363 · Cited by 45
“In addition, associations between weightadjusted muscle mass rather than height-adjusted muscle mass and cardio metabolic health have been reported extensively.(34,35) Finally, the definition of diastolic dysfunction in this study was according to the previous guidelines used in 2009(44) and 2016(45) due to the lack o…”
MethodSelf-citationSaner, N. J., Bishop, D. J., & Bartlett, J. D. (2018) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2017.01.001 · Cited by 41
Lee, S., Lee, Y., Kim, K. J., Lee, W., Kwon, O., & Kim, J. (2013) · Osteoporosis International · doi:10.1007/s00198-013-2378-6 · Cited by 45
“A number of cardiometabolic disorders, including diabetes mellitus, metabolic syndrome, and coronary artery disease, have been also associated with sarcopenia [11–14].”
BackgroundSelf-citationKim, K. M., Lim, S. K., Choi, S. H., Kim, J. H., Shin, C. S., Park, K. S., & Jang, H. C. (2014) · IJC Metabolic & Endocrine · doi:10.1016/j.ijcme.2014.06.001 · Cited by 42
Self-citationHandgrip Strength Among Korean Adolescents With Metabolic Syndrome in 2014–2015
Kang, Y., Park, S., Kim, S., & Koh, H. (2018) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2018.09.002 · Cited by 41
The Association between Nonalcoholic Fatty Liver Disease and CT-Measured Skeletal Muscle Mass
Choe, E. K., Kang, H. Y., Park, B., Yang, J. I., & Kim, J. S. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7100310 · Cited by 41
Self-citationSarcopenic obesity and insulin resistance: Application of novel body composition models
Poggiogalle, E., Mendes, I. C., Ong, B., Prado, C. M. M., Mocciaro, G., Mazidi, M., Lubrano, C., Lenzi, A., Donini, L. M., & Siervo, M. (2020) · Nutrition · doi:10.1016/j.nut.2020.110765 · Cited by 45
Kwon, Y., & Jeong, S. J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103355 · Cited by 40
“However, so far, studies have been limited to adults, most of whom were obese, because sarcopenia was originally described in elderly individuals [9], and a clear association has been reported to exist between sarcopenia and obesity [21].”
BackgroundCho, J., Park, M., Moon, W., Han, S., & Moon, Y. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05728-8 · Cited by 42
Sarcopenic obesity is significantly associated with coronary artery calcification
Chung, G. E., Park, H. E., Lee, H., Kim, M. J., Choi, S.-Y., Yim, J. Y., & Yoon, J. W. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.651961 · Cited by 39
“Moreover, SO was associated with a higher risk for dyslipidemia (20), metabolic syndrome (26), diabetes (27), and hypertension (28) than sarcopenia or obesity alone.”
BackgroundSelf-citationZhou, Y., Wang, J., Yao, Q., Jian, Q.-F., & Luo, Z.-P. (2023) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2023.09.920 · Cited by 44
Mo, D., Hsieh, P., Yu, H., Zhou, L., Gong, J., Xu, L., Liu, P., Chen, G., Chen, Z., & Deng, Q. (2018) · Archives of Osteoporosis · doi:10.1007/s11657-018-0481-1 · Cited by 41
Hsing, J. C., Nguyen, M. H., Yang, B., Yan, M., Han, S. S., Pung, E., Winter, S. J., Zhao, X., Gan, D., Hsing, A. W., et al. (2019) · Hepatology Communications · doi:10.1002/hep4.1392 · Cited by 41
“Muscle mass was defined by the skeletal muscle mass index (SMI), which was calculated by dividing the appendicular lean mass (ALM) (g) by total body weight (g) and multiplying by 100.(7,14) ALM was defined as the summation of both arm and leg lean mass.”
MethodNishigori, T., Obama, K., & Sakai, Y. (2020) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh.2019.10.13 · Cited by 41
Sung, M. J., Lim, T. S., Jeon, M. Y., Lee, H. W., Kim, B. K., Kim, D. Y., Ahn, S. H., Han, K., Park, J. Y., & Kim, S. U. (2020) · Gut and Liver · doi:10.5009/gnl19126 · Cited by 41
Lee, J., Lee, H. S., Cho, A., Lee, Y., & Kwon, Y. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.01.016 · Cited by 44
Jun, J. E., Lee, S.-E., Lee, Y., Kim, G., Jin, S., Jee, J. H., & Kim, J. H. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac662 · Cited by 40
Self-citationKim, T. H., Hwang, H., & Kim, S.-H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090105 · Cited by 44
“In this study, we used a definition of sarcopenia in which ASM was taken as a percentage of body weight because this showed a closer association with metabolic parameters than when defined by ASM/height2 [45].”
MethodYu, B., Jia, S., Sun, T., Liu, J., Jin, J., Zhang, S., Xiao, Q., Dong, H., & Ou, Y. (2024) · The journal of nutrition health & aging · doi:10.1016/j.jnha.2024.100353 · Cited by 44
Metadata
- Authors
- Lim, S., Kim, J. H., Yoon, J. W., Kang, S. M., Choi, S. H., Park, Y. J., Kim, K. W., Lim, J. Y., Park, K. S., & Jang, H. C.
- Affiliations
- Seoul National University (KR)
- Corresponding author
- Jang, Hak Chul
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-05-11
- Volume
- 33
- Issue
- 7
- Pages
- 1652-1654
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2890376
- OpenAlex
- W2055418044
- Cited by
- 588
- References
- 17
- Citations by year
- 2026: 16 · 2025: 27 · 2024: 43 · 2023: 38 · 2022: 48 · 2021: 50 · 2020: 41 · 2019: 50 · 2018: 48 · 2017: 35 · 2016: 50 · 2015: 50 · 2014: 31 · 2013: 26 · 2012: 23
- FWCI
- 12.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Seoul National University Open Repository (Seoul National University) (submittedVersion)
- Funders
- American Diabetes Association
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- sarcopenic obesity, sarcopenia, obesity, metabolic syndrome, prevalence, older adults, appendicular skeletal muscle mass, visceral fat area, insulin resistance, sex differences
- MeSH terms
- Aged, Aged, 80 and over, Aging, Female, Humans, Insulin Resistance, Longitudinal Studies, Male, Obesity, Risk Factors, Prevalence, Logistic Models, Sex Distribution, Metabolic Syndrome, Asian People, Sarcopenia, Republic of Korea
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.